Cold Genesys

1024 679 ORI Capital

Cold Genesys is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies, including an oncolytic virus for the treatment of bladder cancer and a variety of other solid tumor types.

www.coldgenesys.com